HealthDay Reports: Physicians Report Expanding Use of Off-Label COVID-19 Treatments
The use of the anti-malarial drug hydroxychloroquine is increasing rapidly for treating COVID-19 around the world, although plasma from recovered COVID-19 patients is perceived as more effective than the anti-malarial drug at treating coronavirus.
Physicians Report Expanding Use of Off-Label COVID-19 Treatments
MONDAY, April 13, 2020 (HealthDay News) -- Hydroxychloroquine usage is expanding globally to treat coronavirus 2019 (COVID-19), although plasma from recovered patients is perceived as more effective than hydroxychloroquine, according to a report released by Sermo.
Sermo, a global health care polling company and social platform for physicians, released results of its Real Time Barometer study (March 30 to April 2) to understand COVID-19 treatments and their efficacy. A minimum of 250 respondents per country for 30 countries participated (United States, Canada, Argentina, Brazil, Mexico, Germany, Italy, the United Kingdom, France, Spain, Belgium, Netherlands, Sweden, Turkey, Poland, Russia, Finland, Ireland, Switzerland, Austria, Denmark, Norway, Greece, Taiwan, Japan, South Korea, Australia, China, India, and Hong Kong).
Read the full HealthDay story.